Profound muscle weakness and pain after one dose of actonel
- PMID: 19826634
- PMCID: PMC2760234
- DOI: 10.1155/2009/693014
Profound muscle weakness and pain after one dose of actonel
Abstract
The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000. Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000. Bisphosphonates are a group of medications used to treat osteoporosis, Padget's disease of bone, and osteopenia. We report a woman who developed profound muscle weakness and pain after one dose of Risedronate (Actonel).
References
-
- Iqbal MM. Osteoporosis: epidemiology, diagnosis, and treatment. Southern Medical Journal. 2000;93(1):2–18. - PubMed
-
- Physicians' Desk Reference: PDR-Actonel Tablets. 2007. (MICROMEDEX Healthcare).
-
- Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) database consortium. Archives of Physical Medicine and Rehabilitation. 1996;77(12):1251–1255. - PubMed
-
- U.S. Department of Health & Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. 2004.
-
- Wysowski DK, Chang JT. Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Archives of Internal Medicine. 2005;165(3):346–347. - PubMed
Publication types
LinkOut - more resources
Full Text Sources